持續正壓呼吸器市場:現狀分析與預測(2022-2030年)

持續氣道正壓通氣 (CPAP) 是氣道正壓通氣的一種形式，其中大於大氣壓的穩定壓力持續施加到人的上呼吸道。CPAP 市場的增長歸因於多種因素，例如全球範圍內糖尿病、高血壓、肥胖、阻塞性睡眠呼吸暫停 (OSA) 和呼吸困難等肺部疾病患病率的上升，需求不斷增長。

由於睡眠呼吸暫停病例及相關病症數量的增加，以及患有呼吸系統疾病的老年人口的急劇增加，持續氣道正壓通氣市場預計將以約6.4%的穩定速度增長。此外，全球人口正在迅速老齡化，老年人口呼吸系統疾病患病率的增加是市場增長的一個突出因素。老年人也更容易患慢性阻塞性肺病 (COPD)、哮喘和睡眠呼吸暫停等呼吸系統疾病，這推動了對 CPAP 設備的需求。例如，據報導，2020年有1250萬人，即成年人的5.0%，被診斷患有COPD（慢性阻塞性肺病、慢性支氣管炎、肺氣腫）。

按組件劃分，市場分為 CPAP 面罩、CPAP 加濕器等。其中，CPAP加濕器品類在2021年市場佔據主導地位。CPAP 加濕器是 CPAP 機器的重要配件，正在推動 CPAP 設備市場的增長。睡眠呼吸暫停和其他呼吸系統疾病的患病率不斷增加，人們對 CPAP 治療益處的認識不斷提高，以及負擔得起的便攜式 CPAP 設備的可用性不斷增加，這些都是推動市場增長的一些主要因素。

按應用，市場分為睡眠呼吸暫停綜合徵和慢性阻塞性肺病。其中，由於老年人群中阻塞性睡眠呼吸暫停 (OSA) 病例的增加以及對 OSA 或其他呼吸系統疾病的認識的提高，睡眠呼吸暫停類別將在 2022 年佔據市場主導地位，預計將在預測期內推動市場增長。例如，根據歐洲呼吸學會公佈的數據，歐洲約有13.0%至32.0%的老年人口患有睡眠呼吸暫停。

根據最終用戶，市場分為醫院和診所、家庭護理等。其中，家庭護理類別在 2022 年佔據市場主導地位。這主要是因為市場參與者正在專注於推出可供接受疾病治療的人在家中使用的新型便攜式設備。人們越來越傾向於在家中進行 OSA 治療，尤其是在美國、英國、德國和日本等國家，這推動了家庭護理和其他環境中對這些設備的需求。

為了更好地了解持續氣道正壓通氣行業的市場採用情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、意大利、歐洲其他地區） 、亞太地區（中國、日本、印度和亞太地區其他地區）和世界其他國家根據其全球影響力進行分析。由於其完善的醫療基礎設施和高科技的採用，預計北美在預測期內將主導全球 CPAP 設備市場。此外，該國睡眠呼吸暫停綜合症的負擔正在增加，這推動了 CPAP 設備市場的增長。例如，睡眠呼吸暫停組織估計有 2200 萬美國人患有睡眠呼吸暫停，並且 80%?? 的中度和重度阻塞性睡眠呼吸暫停未被診斷出來。

目錄

第1章 市場簡介

• 市場定義
• 主要目的
• 相關利益者
• 限制事項

第2章 調查手法或前提

• 調查流程
• 調查手法
• 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對持續正壓呼吸器市場帶來的影響

第6章 持續正壓呼吸器市場收益，2020-2030年

第7章 市場洞察:各零件

• CPAP面罩
• CPAP加濕器
• 其他

第8章 市場洞察:各用途

• 睡眠呼吸中止症
• COPD

第9章 市場洞察:各終端用戶

• 醫院和診所
• 居家護理
• 其他

第10章 市場洞察:各地區

• 北美
  • 美國
  • 加拿大
  • 其他北美地區
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 全球其他地區

第11章 持續正壓呼吸器市場動態

• 推動市場要素
• 市場課題
• 影響分析

第12章 持續正壓呼吸器市場機會

第13章 持續正壓呼吸器市場趨勢

第14章 需求面和供給面的分析

• 需求面分析
• 供給面分析

第15章 價值鏈分析

第16章 價格分析

第17章 策略性洞察能力

第18章 競爭模式

• 競爭情形
  • 波特的五力分析

第19章 企業簡介

• BMC
• ResMed
• Fisher & Paykel Healthcare Limited
• Drive DeVilbiss Healthcare
• Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
• Smiths Group plc
• Airing
• Koninklijke Philips N.V.
• Honeywell International Inc.
• Transcend, Inc.

第20章 免責聲明

Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. The growth of the CPAP market is attributed due to several factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea globally, which is to higher demand for CPAP devices. For instance, according to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%.

The continuous positive airway pressure market is expected to grow at a steady rate of around 6.4% owing to the increasing number of sleep apnea cases and related conditions and the surging geriatric population with respiratory diseases. Moreover, the global population is aging at a rapid pace, leading to an increased prevalence of respiratory diseases among the elderly population which is a prominent factor in the growth of the market. Also, older adults are more susceptible to respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea which will drive the demand for CPAP devices. For instance, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.

Based on component, the market is segmented into CPAP masks, CPAP humidifiers, and others. Among them, the CPAP humidifiers category dominated the market in 2021. CPAP humidifiers are an essential accessory for CPAP machines and are driving the growth of the CPAP devices market. The increasing prevalence of sleep apnea and other respiratory disorders, the growing awareness of the benefits of CPAP therapy, and the increasing availability of affordable and portable CPAP devices are some of the key factors contributing to the market's growth.

Based on application, the market is bifurcated into sleep apnea and COPD. Among them, the sleep apnea category dominated the market in 2022 owing to the growing obstructive sleep apnea (OSA) cases in the geriatric population and the rising awareness for OSA or other respiratory diseases will drive the growth of the market during the forecast period. For instance, according to the data published by the European Respiratory Society, approximately 13.0% to 32.0% of the geriatric population in Europe was suffering from sleep apnea.

Based on end-user, the market is segmented into hospitals & clinics, home care, and others. Among them, the home care category dominated the market in 2022. This is mainly due to the players in the market concentrating on launching new, portable devices that can be used at home among those undergoing treatment for the condition. This, along with a growing preference for treating OSA at home, is driving up demand for these devices in-home care and other settings, particularly in countries like the U.S., the U.K., Germany, and Japan, among others.

For a better understanding of the market adoption of the continuous positive airway pressure industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to dominate the global CPAP devices market during the forecast period due to the presence of well-established healthcare infrastructure and higher adoption of technology in the country. Also, the country is witnessing the growing burden of sleep apnea which in turn is facilitating the CPAP devices market growth. For instance, according to sleep apnea org, It is estimated that 22 million Americans suffer from sleep apnea, with 80 percent of the cases of moderate and severe obstructive sleep apnea undiagnosed.

Some of the major players operating in the market include: BMC; ResMed; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare; Shanghai Fosun Pharmaceutical Group Co., Ltd.; Smiths Group plc; Airing; Koninklijke Philips N.V.; Honeywell International Inc.; and Transcend, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Continuous Positive Airway Pressure Devices Market
• 2.2. Research Methodology of the Continuous Positive Airway Pressure Devices Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET

6 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY COMPONENT

• 7.1. CPAP Mask
• 7.2. CPAP Humidifier
• 7.3. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Sleep Apnea
• 8.2. COPD

9 MARKET INSIGHTS BY END-USER

• 9.1. Hospitals & Clinics
• 9.2. Home Care
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET OPPORTUNITIES

13 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

• 19.1. BMC
• 19.2. ResMed
• 19.3. Fisher & Paykel Healthcare Limited
• 19.4. Drive DeVilbiss Healthcare
• 19.5. Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
• 19.6. Smiths Group plc
• 19.7. Airing
• 19.8. Koninklijke Philips N.V.
• 19.9. Honeywell International Inc.
• 19.10. Transcend, Inc.

20 DISCLAIMER